Thomas Ryll is SVP, Technical Operations of ImmunoGen, Inc.. Currently has a direct ownership of 84,714 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 3,849 shares (Common Stock) at a price of $5.52 per share, resulting in proceeds of $21,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.7K
0% 3M change
0% 12M change
Total Value Held $0

Thomas Ryll Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Grant, award, or other acquisition
$21,246 $5.52 p/Share
3,849 Added 4.35%
84,714 Common Stock
TR

Thomas Ryll

SVP, Technical Operations
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Track Activities on IMGN